Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

Guillermo Garcia-Manero; Maria Diez-Campelo; Edo Vellenga; Meagan A Jacoby; Brayan Merchan; Dimitri Breems; Agostino Cortelezzi; Vadim Doronin; Valle Gomez; Marielle Beckers; Matteo Giovanni Della Porta; Helen Varsos; Liang Xiu; Nikki DeAngelis; Ivo Nnane; Esther Rose; Koen van Eygen

doi:10.1002/ajh.26095

Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

Guillermo Garcia-Manero^*, Maria Diez-Campelo, Edo Vellenga, Meagan A Jacoby, Brayan Merchan, Dimitri Breems, Agostino Cortelezzi, Vadim Doronin, Valle Gomez, Marielle Beckers, Matteo Giovanni Della Porta, Helen Varsos, Liang Xiu, Nikki DeAngelis, Ivo Nnane, Esther Rose, Koen van Eygen

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

41 Downloads (Pure)

Original language	English
Pages (from-to)	E111-E114
Number of pages	4
Journal	American Journal of Hematology
Volume	96
Issue number	4
Early online date	15-Jan-2021
DOIs	https://doi.org/10.1002/ajh.26095
Publication status	Published - Apr-2021

Access to Document

10.1002/ajh.26095

Daratumumab in transfusion‐dependent patients with low or intermediate‐1 risk myelodysplastic syndromesFinal publisher's version, 832 KBLicence: Taverne

Handle.net

Persistent link

Cite this

Garcia-Manero, G., Diez-Campelo, M., Vellenga, E., Jacoby, M. A., Merchan, B., Breems, D., Cortelezzi, A., Doronin, V., Gomez, V., Beckers, M., Porta, M. G. D., Varsos, H., Xiu, L., DeAngelis, N., Nnane, I., Rose, E., & van Eygen, K. (2021). Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes. American Journal of Hematology, 96(4), E111-E114. https://doi.org/10.1002/ajh.26095

@article{29d11ec02ba14d5d83b282bdc660fdad,

title = "Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes",

author = "Guillermo Garcia-Manero and Maria Diez-Campelo and Edo Vellenga and Jacoby, {Meagan A} and Brayan Merchan and Dimitri Breems and Agostino Cortelezzi and Vadim Doronin and Valle Gomez and Marielle Beckers and Porta, {Matteo Giovanni Della} and Helen Varsos and Liang Xiu and Nikki DeAngelis and Ivo Nnane and Esther Rose and {van Eygen}, Koen",

note = "Funding Information: Guillermo Garcia‐Manero, Matteo Giovanni Della Porta, Helen Varsos, Liang Xiu, Esther Rose, and Koen van Eygen contributed to study design; Guillermo Garcia‐Manero, Edo Vellenga, Meagan A. Jacoby, Brayan Merchan, Dimitri Breems, Agostino Cortelezzi, Vadim Doronin, Valle Gomez, Marielle Beckers, Matteo Giovanni Della Porta, Helen Varsos, and Esther Rose acquired the data; Guillermo Garcia‐Manero, Maria Diez‐Campelo, Dimitri Breems, Marielle Beckers, Matteo Giovanni Della Porta, Nikki DeAngelis, Ivo Nnane, and ER analyzed or interpreted the data; all authors contributed to drafting and revising the manuscript and approved it for submission. Medical writing support was provided by Grace Wang, PharmD, of MedErgy, and was funded by Janssen Global Services, LLC.",

year = "2021",

month = apr,

doi = "10.1002/ajh.26095",

language = "English",

volume = "96",

pages = "E111--E114",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley",

number = "4",

}

Garcia-Manero, G, Diez-Campelo, M, Vellenga, E, Jacoby, MA, Merchan, B, Breems, D, Cortelezzi, A, Doronin, V, Gomez, V, Beckers, M, Porta, MGD, Varsos, H, Xiu, L, DeAngelis, N, Nnane, I, Rose, E & van Eygen, K 2021, 'Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes', American Journal of Hematology, vol. 96, no. 4, pp. E111-E114. https://doi.org/10.1002/ajh.26095

TY - JOUR

T1 - Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

AU - Garcia-Manero, Guillermo

AU - Diez-Campelo, Maria

AU - Vellenga, Edo

AU - Jacoby, Meagan A

AU - Merchan, Brayan

AU - Breems, Dimitri

AU - Cortelezzi, Agostino

AU - Doronin, Vadim

AU - Gomez, Valle

AU - Beckers, Marielle

AU - Porta, Matteo Giovanni Della

AU - Varsos, Helen

AU - Xiu, Liang

AU - DeAngelis, Nikki

AU - Nnane, Ivo

AU - Rose, Esther

AU - van Eygen, Koen

N1 - Funding Information: Guillermo Garcia‐Manero, Matteo Giovanni Della Porta, Helen Varsos, Liang Xiu, Esther Rose, and Koen van Eygen contributed to study design; Guillermo Garcia‐Manero, Edo Vellenga, Meagan A. Jacoby, Brayan Merchan, Dimitri Breems, Agostino Cortelezzi, Vadim Doronin, Valle Gomez, Marielle Beckers, Matteo Giovanni Della Porta, Helen Varsos, and Esther Rose acquired the data; Guillermo Garcia‐Manero, Maria Diez‐Campelo, Dimitri Breems, Marielle Beckers, Matteo Giovanni Della Porta, Nikki DeAngelis, Ivo Nnane, and ER analyzed or interpreted the data; all authors contributed to drafting and revising the manuscript and approved it for submission. Medical writing support was provided by Grace Wang, PharmD, of MedErgy, and was funded by Janssen Global Services, LLC.

PY - 2021/4

Y1 - 2021/4

U2 - 10.1002/ajh.26095

DO - 10.1002/ajh.26095

M3 - Letter

C2 - 33448430

SN - 0361-8609

VL - 96

SP - E111-E114

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -